CD38 and Miyoshi myopathy: An in vitro study of CD38+ MM tumor cell lines demonstrated that daratumumab‐mediated apoptosis occurs after cross‐linking by cells expressing either activating FcγR or the inhibitory FcγRIIb.81, 92